Dr. Saule Balmagambetova is an Associate Professor at the Oncology Department of the West Kazakhstan Marat Ospanov Medical University. After graduating from the West Kazakhstan Medical University, worked as a gynecologist for many years. In 2013 graduated from the Harvard Medical School course "Principles and Practice of Clinical Research," certified in Clinical Research, and since 2014, certified as a gynecologic oncologist and a chemotherapist (2019.) The Ph.D. thesis was focused on HPV and cervical cancer epidemiological and genetic aspects across western Kazakhstan (2018). Designer and Principal Investigator of scientific projects of republican importance on oncologic diseases of women's reproductive system. Professional areas: General Oncology, Oncologic Epidemiology, Gynecologic Oncology. Research focus: multimodal treatment of Breast cancer; cardiotoxicity of chemotherapy; cervical cancer; so-called "weak" HPV types and their role in cervical pathology; cancer screening issues. Currently is a Principal Investigator of the project on Breast cancer chemotherapy-linked cardiotoxicity.
Dr. Saule Balmagambetova is an Associate Professor at the Oncology Department of the West Kazakhstan Marat Ospanov Medical University. After graduating from the West Kazakhstan Medical University, worked as a gynecologist for many years. In 2013 graduated from the Harvard Medical School course "Principles and Practice of Clinical Research," certified in Clinical Research, and since 2014, certified as a gynecologic oncologist and a chemotherapist (2019.) The Ph.D. thesis was focused on HPV and cervical cancer epidemiological and genetic aspects across western Kazakhstan (2018). Designer and Principal Investigator of scientific projects of republican importance on oncologic diseases of women's reproductive system. Professional areas: General Oncology, Oncologic Epidemiology, Gynecologic Oncology. Research focus: multimodal treatment of Breast cancer; cardiotoxicity of chemotherapy; cervical cancer; so-called "weak" HPV types and their role in cervical pathology; cancer screening issues. Currently is a Principal Investigator of the project on Breast cancer chemotherapy-linked cardiotoxicity.